论文信息 - Clinical outcomes of second‐generation tyrosine kinase inhibitors versus imatinib in older patients with CML - 字舞流文

Clinical outcomes of second‐generation tyrosine kinase inhibitors versus imatinib in older patients with CML

T. Naoe | R. Suzuki | M. Kizaki | I. Matsumura | T. Kawaguchi | K. Ohnishi | Kazuhito Yamamoto | T. Ono | N. Takahashi